|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.50 GBX | 0.00% |
|
-4.17% | -2.13% |
| 12-10 | Ixico Bags Imaging Services Deal with US Client | MT |
| 12-10 | IXICO plc Wins US Client Clinical Trial Contract | CI |
| Capitalization | 10.66M 13.01M 12.62M 11.87M 18.67M 1.13B 21.01M 145M 53.67M 461M 48.76M 47.8M 2.06B | P/E ratio 2025 * |
-5.48x | P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 7.76M 9.47M 9.19M 8.64M 13.59M 819M 15.29M 106M 39.07M 336M 35.49M 34.79M 1.5B | EV / Sales 2025 * |
1.28x | EV / Sales 2026 * | - |
| Free-Float |
69.39% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: IXICO plc
More press releases
| 1 week | -4.17% | ||
| Current month | -2.13% | ||
| 3 months | +24.32% | ||
| 6 months | +64.29% | ||
| Current year | -2.13% |
1 week
11.00
12.50
1 month
11.0012.50
Current year
11.0012.50
1 year
6.3513.00
3 years
6.3562.00
5 years
6.35127.00
10 years
6.35127.00
| Director | Title | Age | Since |
|---|---|---|---|
Bram Goorden
CEO | Chief Executive Officer | 51 | 18/08/2024 |
Grant Nash
DFI | Director of Finance/CFO | 48 | 20/08/2019 |
Romina Oxborough
COO | Chief Operating Officer | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Warne
CHM | Chairman | 49 | - |
Grant Nash
BRD | Director/Board Member | 48 | 20/08/2019 |
| Director/Board Member | 58 | 20/01/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -4.17% | -9.80% | -80.83% | 12.96M | ||
| -1.29% | -0.81% | +45.87% | -19.53% | 42.78B | ||
| -3.26% | -0.66% | -7.43% | -21.47% | 37.14B | ||
| +0.38% | +0.44% | -1.61% | +3.32% | 26.99B | ||
| -8.14% | -7.09% | -21.47% | -27.10% | 18B | ||
| +0.50% | +2.62% | +66.49% | +75.34% | 16.2B | ||
| -1.96% | -19.05% | -67.48% | -83.60% | 13.53B | ||
| -2.21% | +0.65% | +3.55% | -24.83% | 12.14B | ||
| -5.99% | -3.26% | +15.41% | +83.55% | 10.92B | ||
| -0.93% | +1.76% | -1.60% | -9.16% | 10.22B | ||
| Average | -2.28% | -0.66% | +2.19% | -10.43% | 18.79B | |
| Weighted average by Cap. | -2.29% | +0.18% | +8.60% | -7.58% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.05M 7.39M 7.17M 6.74M 10.6M 639M 11.93M 82.57M 30.47M 262M 27.68M 27.13M 1.17B | - |
| Net income | -1.78M -2.18M -2.11M -1.99M -3.12M -188M -3.52M -24.33M -8.98M -77.21M -8.16M -8M -344M | - |
| Net Debt | -2.9M -3.54M -3.44M -3.23M -5.08M -306M -5.72M -39.58M -14.6M -126M -13.27M -13.01M -559M | - |
More financial data
* Estimated data
Employees
81
Calendar
24/01/2025
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/25 | 11.50 p | 0.00% | 14,200 |
| 13/01/25 | 11.50 p | -2.13% | 88,702 |
| 10/01/25 | 11.75 p | 0.00% | 5,991 |
| 09/01/25 | 11.75 p | +4.44% | 23,200 |
| 08/01/25 | 11.25 p | -6.25% | 21,678 |
Delayed Quote London S.E., January 14, 2025 at 04:35 pm
More quotes
Annual profits - Rate of surprise
- Stock Market
- Equities
- IXI Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition